Cargando…
Impact of the Covid-19 epidemic on a US sample of patients with myasthenia gravis
INTRODUCTION: The Covid-19 pandemic has devastated the world and demonstrated the inadequacy of health care in the United States. To assess its impact, the Rare Disease Clinical Research Network conducted a survey to assess the pandemic on the rare disease community of patients, including those with...
Autores principales: | Gutierrez, Gloria, Girma, Helen, Kuhnell, Pierce, Macaluso, Maurizio, Kaminski, Henry J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032427/ https://www.ncbi.nlm.nih.gov/pubmed/37125217 http://dx.doi.org/10.1177/26330040221082673 |
Ejemplares similares
-
Corticosteroid Treatment-Resistance in Myasthenia Gravis
por: Kaminski, Henry J., et al.
Publicado: (2022) -
Eye Segmentation Method for Telehealth: Application to the Myasthenia Gravis Physical Examination
por: Lesport, Quentin, et al.
Publicado: (2023) -
Complement Inhibitor Therapy for Myasthenia Gravis
por: Albazli, Khaled, et al.
Publicado: (2020) -
Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study
por: McPherson, Tarrant, et al.
Publicado: (2020) -
Monoclonal Antibody-Based Therapies for Myasthenia Gravis
por: Alabbad, Sawsan, et al.
Publicado: (2020)